7/102 sources · 2 publishersUpdated Nov 9, 17:26 UTC
Piper Sandler lifts Humana price target to $526 from $463
Piper Sandler raised its price target for Humana Inc. to $526, up from $463, while keeping an Overweight rating. The upgrade follows Humana's third‑quarter 2026 adjusted earnings per share beat of $0.30 and a $0.50 increase to its 2026 guidance. The firm also highlighted a path to $40.45 adjusted EPS in 2028 and expects further Medicare Advantage margin expansion.
Why it matters
The higher target implies a potential 21.3% upside from the recent close, according to Piper Sandler. Investors may reassess Humana's valuation based on the upgraded outlook.
Key facts
- 1Piper Sandler raised Humana's price target to $526 from $463. investing.com
- 2Humana posted third‑quarter 2026 adjusted EPS of $0.30, beating expectations. investing.com
- 3Humana increased its calendar‑year 2026 adjusted EPS guidance by $0.50 to at least $9.50. investing.com
- 4Revenue for the quarter was $41.2 billion, above the consensus estimate of $40.9 billion. investing.com
- 5Piper Sandler sees a clear path to $40.45 of adjusted EPS in calendar year 2028. investing.com
- 6The analyst cites a 21.3% upside from the November 6 close after raising the target. tradingview.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.